HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $482,017,259 | +5.7% | 5,380,858 | +0.5% | 0.01% | +9.1% |
| Q2 2023 | $455,815,039 | +3.4% | 5,353,712 | +0.5% | 0.01% | 0.0% |
| Q1 2023 | $440,642,675 | +6.9% | 5,324,987 | +1.6% | 0.01% | 0.0% |
| Q4 2022 | $412,349,052 | +7.2% | 5,242,836 | +0.9% | 0.01% | 0.0% |
| Q3 2022 | $384,600,000 | +17.5% | 5,195,195 | +3.4% | 0.01% | +22.2% |
| Q2 2022 | $327,340,000 | +5.5% | 5,022,082 | +2.3% | 0.01% | +28.6% |
| Q1 2022 | $310,404,000 | +19.9% | 4,909,896 | +0.6% | 0.01% | +16.7% |
| Q4 2021 | $258,884,000 | -25.0% | 4,880,936 | -0.1% | 0.01% | -33.3% |
| Q3 2021 | $345,007,000 | +5.9% | 4,887,478 | -0.0% | 0.01% | +12.5% |
| Q2 2021 | $325,715,000 | -39.9% | 4,887,681 | +0.1% | 0.01% | -46.7% |
| Q1 2021 | $542,130,000 | -5.9% | 4,883,613 | +0.6% | 0.02% | -11.8% |
| Q4 2020 | $576,208,000 | +35.8% | 4,852,282 | -0.3% | 0.02% | +21.4% |
| Q3 2020 | $424,457,000 | -10.6% | 4,864,834 | -8.2% | 0.01% | -17.6% |
| Q2 2020 | $474,758,000 | -13.8% | 5,301,013 | -4.0% | 0.02% | -26.1% |
| Q1 2020 | $550,472,000 | -8.4% | 5,523,488 | +5.6% | 0.02% | +15.0% |
| Q4 2019 | $601,064,000 | -9.2% | 5,231,195 | -0.3% | 0.02% | -20.0% |
| Q3 2019 | $662,057,000 | -1.7% | 5,248,592 | -6.2% | 0.02% | 0.0% |
| Q2 2019 | $673,462,000 | +36.6% | 5,596,332 | -0.7% | 0.02% | +31.6% |
| Q1 2019 | $492,997,000 | -12.3% | 5,635,532 | +0.3% | 0.02% | -24.0% |
| Q4 2018 | $562,281,000 | -12.7% | 5,619,997 | +0.0% | 0.02% | 0.0% |
| Q3 2018 | $643,906,000 | +30.3% | 5,619,707 | +1.9% | 0.02% | +19.0% |
| Q2 2018 | $494,349,000 | +19.7% | 5,512,350 | -2.4% | 0.02% | +16.7% |
| Q1 2018 | $413,147,000 | +41.8% | 5,647,160 | +12.6% | 0.02% | +38.5% |
| Q4 2017 | $291,370,000 | +32.9% | 5,016,695 | +2.7% | 0.01% | +30.0% |
| Q3 2017 | $219,201,000 | +17.0% | 4,885,262 | +3.0% | 0.01% | +11.1% |
| Q2 2017 | $187,303,000 | -1.7% | 4,743,044 | +1.0% | 0.01% | -10.0% |
| Q1 2017 | $190,449,000 | +8.6% | 4,694,325 | +7.6% | 0.01% | 0.0% |
| Q4 2016 | $175,361,000 | +15.5% | 4,362,238 | +4.0% | 0.01% | +11.1% |
| Q3 2016 | $151,881,000 | +29.8% | 4,194,443 | +3.9% | 0.01% | +28.6% |
| Q2 2016 | $117,035,000 | -15.7% | 4,037,091 | +1.8% | 0.01% | -22.2% |
| Q1 2016 | $138,758,000 | +12.2% | 3,966,792 | +3.4% | 0.01% | +12.5% |
| Q4 2015 | $123,701,000 | -75.9% | 3,836,928 | -76.1% | 0.01% | -57.9% |
| Q3 2015 | $513,470,000 | +230.2% | 16,031,964 | +326.4% | 0.02% | +72.7% |
| Q2 2015 | $155,520,000 | -5.1% | 3,760,148 | +3.0% | 0.01% | 0.0% |
| Q1 2015 | $163,937,000 | +25.9% | 3,649,530 | +4.9% | 0.01% | +22.2% |
| Q4 2014 | $130,211,000 | +7.7% | 3,479,732 | +0.5% | 0.01% | 0.0% |
| Q3 2014 | $120,890,000 | -1.1% | 3,461,909 | -0.1% | 0.01% | -10.0% |
| Q2 2014 | $122,268,000 | +6.0% | 3,465,654 | -2.1% | 0.01% | 0.0% |
| Q1 2014 | $115,317,000 | -19.5% | 3,538,417 | +4.1% | 0.01% | -23.1% |
| Q4 2013 | $143,225,000 | +12.5% | 3,399,584 | +6.5% | 0.01% | +8.3% |
| Q3 2013 | $127,269,000 | -0.6% | 3,191,289 | +3.1% | 0.01% | -7.7% |
| Q2 2013 | $128,007,000 | – | 3,095,702 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |